276 related articles for article (PubMed ID: 21785820)
21. Head and neck squamous cell carcinoma in non-smoking and non-drinking patients with multiple tumors: etiologic significance of p53 and Ki-67 in non-tumorous epithelium.
Farshadpour F; Hordijk GJ; Koole R; Slootweg PJ
J Oral Pathol Med; 2008 Oct; 37(9):549-54. PubMed ID: 18331287
[TBL] [Abstract][Full Text] [Related]
22. Chemoprevention of squamous cell carcinoma of the head and neck.
Wrangle JM; Khuri FR
Curr Opin Oncol; 2007 May; 19(3):180-7. PubMed ID: 17414634
[TBL] [Abstract][Full Text] [Related]
23. Metabolism and growth inhibition of four retinoids in head and neck squamous normal and malignant cells.
Klaassen I; Brakenhoff RH; Smeets SJ; Snow GB; Braakhuis BJ
Br J Cancer; 2001 Aug; 85(4):630-5. PubMed ID: 11506507
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of chromosome 3p deletion on the expression of the putative tumor suppressor RAR beta and on retinoid resistance in human squamous carcinoma cells.
Zou CP; Youssef EM; Zou CC; Carey TE; Lotan R
Oncogene; 2001 Oct; 20(47):6820-7. PubMed ID: 11687961
[TBL] [Abstract][Full Text] [Related]
25. In vivo Wnt pathway inhibition of human squamous cell carcinoma growth and metastasis in the chick chorioallantoic model.
Rudy SF; Brenner JC; Harris JL; Liu J; Che J; Scott MV; Owen JH; Komarck CM; Graham MP; Bellile EL; Bradford CR; Prince ME; Carey TE
J Otolaryngol Head Neck Surg; 2016 Apr; 45():26. PubMed ID: 27117272
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic silencing of CRABP2 and MX1 in head and neck tumors.
Calmon MF; Rodrigues RV; Kaneto CM; Moura RP; Silva SD; Mota LD; Pinheiro DG; Torres C; de Carvalho AF; Cury PM; Nunes FD; Nishimoto IN; Soares FA; da Silva AM; Kowalski LP; Brentani H; Zanelli CF; Silva WA; Rahal P; Tajara EH; Carraro DM; Camargo AA; Valentini SR
Neoplasia; 2009 Dec; 11(12):1329-39. PubMed ID: 20019841
[TBL] [Abstract][Full Text] [Related]
27. Expression of retinoic acid receptor beta is associated with inhibition of keratinization in human head and neck squamous carcinoma cells.
Zou CP; Hong WK; Lotan R
Differentiation; 1999 Jan; 64(2):123-32. PubMed ID: 10234809
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical determination of the appropriate anti-hTERT antibodies for in situ detection of telomerase activity in frozen sections of head and neck squamous cell carcinomas and tumor margin tissues.
Fabricius EM; Kruse-Boitschenko U; Khoury R; Wildner GP; Raguse JD; Klein M
Int J Oncol; 2009 May; 34(5):1257-79. PubMed ID: 19360339
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical examination of 11 cell lines derived from human head and neck squamous cell carcinomas, their recurrences or metastases.
Koldovsky P; Haas I; Bier H; Ganzer U
Eur Arch Otorhinolaryngol; 1995; 252(6):359-65. PubMed ID: 8679156
[TBL] [Abstract][Full Text] [Related]
30. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age.
Olasz J; Juhász A; Remenár E; Engi H; Bak M; Csuka O; Kásler M
Oncol Rep; 2007 Jul; 18(1):105-12. PubMed ID: 17549354
[TBL] [Abstract][Full Text] [Related]
31. Chemoprevention in head and neck cancer.
Mellott A; Vokes E
Cancer Treat Res; 2001; 106():221-35. PubMed ID: 11225004
[No Abstract] [Full Text] [Related]
32. Retinoids: application in premalignant lesions and oral cancer.
Contreras Vidaurre EG; Bagán Sebastián JV; Gavalda C; Torres Cifuentes EF
Med Oral; 2001; 6(2):114-23. PubMed ID: 11500628
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of TP53 mutation-associated microRNA-182 promotes tumor cell proliferation and migration in head and neck squamous cell carcinoma.
Wang L; Jiang H; Li W; Jia C; Zhang H; Sun Y; Chen X; Song X
Arch Oral Biol; 2017 Jan; 73():105-112. PubMed ID: 27744260
[TBL] [Abstract][Full Text] [Related]
34. [Effect of Tiam 1 on cell proliferation and migration in head and neck squamous cell carcinoma cells].
Xiao P; Fu Q; Li Z; Zhang X; Fu X; Wan R
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Apr; 29(7):633-7. PubMed ID: 26201191
[TBL] [Abstract][Full Text] [Related]
35. COX-2 expression in dysplasia of the head and neck: correlation with elF4E.
Nathan CO; Leskov IL; Lin M; Abreo FW; Shi R; Hartman GH; Glass J
Cancer; 2001 Oct; 92(7):1888-95. PubMed ID: 11745262
[TBL] [Abstract][Full Text] [Related]
36. Retinoic acid receptor beta induces terminal differentiation of squamous cell carcinoma lines in the absence of cyclin-dependent kinase inhibitor expression.
Crowe DL
Cancer Res; 1998 Jan; 58(1):142-8. PubMed ID: 9426070
[TBL] [Abstract][Full Text] [Related]
37. IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas.
Wolf JS; Chen Z; Dong G; Sunwoo JB; Bancroft CC; Capo DE; Yeh NT; Mukaida N; Van Waes C
Clin Cancer Res; 2001 Jun; 7(6):1812-20. PubMed ID: 11410524
[TBL] [Abstract][Full Text] [Related]
38. Importance of pharmacodynamics in the in vitro antiproliferative activity of the antifolates methotrexate and 10-ethyl-10-deazaaminopterin against human head and neck squamous cell carcinoma.
Braakhuis BJ; Jansen G; Noordhuis P; Kegel A; Peters GJ
Biochem Pharmacol; 1993 Dec; 46(12):2155-61. PubMed ID: 7506025
[TBL] [Abstract][Full Text] [Related]
39. Differential biomarker expression in head and neck cancer correlates with anatomical localization.
Tamás L; Szentkúti G; Eros M; Dános K; Brauswetter D; Szende B; Zsákovics I; Krenács T
Pathol Oncol Res; 2011 Sep; 17(3):721-7. PubMed ID: 21487776
[TBL] [Abstract][Full Text] [Related]
40. Characterization of miR-146a and miR-155 in blood, tissue and cell lines of head and neck squamous cell carcinoma patients and their impact on cell proliferation and migration.
Lerner C; Wemmert S; Bochen F; Kulas P; Linxweiler M; Hasenfus A; Heinzelmann J; Leidinger P; Backes C; Meese E; Urbschat S; Schick B
J Cancer Res Clin Oncol; 2016 Apr; 142(4):757-66. PubMed ID: 26621153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
